VALENCE Trial: Sofosbuvir and ribavirin in HCV genotypes 2 and 3 Posted on September 6, 2018 by admin - Updated September 7, 2018 2014, Sofosbuvir + ribavirin for HCV, NEJM Gastroenterology, Infectious Disease HCV, hepatology, infection, liver
